Results of surgery for Ebstein anomaly: A multicenter study from the European Congenital Heart Surgeons Association  by Sarris, George E. et al.
S
C
D
R
f
G
G
J
G
S
5
CH
Durgery for
ongenital Heart
iseaseesults of surgery for Ebstein anomaly: A multicenter study
rom the European Congenital Heart Surgeons Association
eorge E. Sarris, MD,a Nikos M. Giannopoulos, MD,a Alexander J. Tsoutsinos, MD,a Andreas K. Chatzis, MD,a
eorge Kirvassilis, MD,a William J. Brawn, MD,b Juan V. Comas, MD,c Antonio F. Corno, MD,d Duccio Di Carlo, MD,e
osè Fragata, MD,f Victor Hraska, MD,g Jeffrey P. Jacobs, MD,h Sofia Krupianko, MD,i Heikki Sairanen, MD,j
iovanni Stellin, MD,k Andreas Urban, MD,l and Gerhard Ziemer, MD,m on behalf of the European Congenital Heart
urgeons Association
O
s
E
m
M
s
J
g
R
f
1
m
2
6
r
pAdditional material is
available online.
Dr Sarris
Earn CME credits at
http://cme.0 The Journal of Thoracic and Cardiovbjective: Since most centers’ experience with Ebstein anomaly is limited, we
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ation.
ethods: The records of all 150 patients (median age 6.4 years) who underwent
urgery for Ebstein anomaly in the 13 participating Association centers between
anuary 1992 and January 2005 were reviewed retrospectively. Patients with con-
enitally corrected transposition were excluded.
esults: Most patients (81%) had Ebstein disease type B or C and significant
unctional impairment (61% in New York Heart Association class III or IV) and
6% had prior operations. Surgical procedures (n  179) included valve replace-
ent (n  60, 33.5%), valve repair (n  49, 27.3%), 1½ ventricle repair (n  46,
5.6%), palliative shunt (n  13, 7.26%), and other complex procedures (n  11,
.14%). There were 20 hospital deaths (operative mortality 13.3%) after valve
eplacement in 5 patients, valve repair in 3, 1½ ventricle repair in 7, palliative
rocedures in 3, and miscellaneous procedures in 2. Younger age and palliative
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Drocedures were univariate risk factors for operative death,
ut only age was an independent predictor on multivariable
nalysis.
onclusions: Most patients coming to surgery presented in
hildhood and were significantly symptomatic. More than
alf underwent valve replacement or repair, but a consider-
ble proportion had severe disease necessitating 1½ ventri-
le repair or palliative procedures. Operative mortality did
ot differ significantly among repair, replacement, and 1½
entricle repair but was associated with palliative proce-
ures for severe disease early in life, young age being the
nly independent predictor of operative death.
bstein anomaly, named after the German pathologist
who first described it1 in 1866, is a rare complex
congenital defect of the tricuspid valve (TV) and the
ight ventricle (RV).2,3 It is characterized by a spectrum of
everal features, the main ones being (1) apical displace-
ent of the functional tricuspid annulus, that is, of the
ttachments primarily of the septal and posterior leaflets,
ith consequent reduction of the functional RV size, (2)
ilation of the “atrialized” portion of the RV with variable
egrees of wall thinning, (3) adherence of the tricuspid
eaflets to the underlying myocardium (failure of delamina-
ion) with redundancy, fenestrations, and tethering of the
nterior leaflet, and (4) dilation of the true tricuspid annulus
atrioventricular junction). These abnormalities cause tri-
uspid regurgitation resulting in right atrial and RV dilata-
ion, substrates for the development of atrial and ventric-
lar arrhythmias. An atrial septal defect (ASD) is usually
resent, allowing right-to-left shunting, resulting in sys-
emic arterial desaturation and cyanosis. In approximately
0% to 15% of patients, accessory conduction pathways
ith Wolff-Parkinson-White syndrome are encountered.4
arpentier and associates5 have proposed a 4-grade classi-
cation of the severity of this anomaly: In type A, the
olume of the true RV is adequate. In type B, there is a large
trialized component of the RV, but the anterior leaflet
oves freely. In type C, the anterior leaflet is severely
estricted in its motion and may also cause significant ob-
truction of the RV outflow tract. Type D is characterized by
lmost complete atrialization of the RV with the exception
f a small infundibular component. A complementary clas-
ification system for Ebstein anomaly has been published by
earani and Danielson2 as part of the International Congen-
tal Heart Surgery Nomenclature and Database Project,
hich was adopted by The Society of Thoracic Surgeons,
he European Association for Cardio-Thoracic Surgery,
nd The European Congenital Heart Surgeons Association
ECHSA). This nomenclature system also describes four fi
The Journal of Thoracypes of Ebstein anomaly based on the morphology of the
nterosuperior leaflet of the TV and then further subclassi-
es each of these four types based on the morphology of the
eading edge of the anterior leaflet.
The wide anatomic spectrum of Ebstein anomaly is re-
ected in an extremely variable clinical presentation and
atural history ranging from very high mortality despite
reatment in symptomatic neonates to long-term survival in
ome adults with and even without treatment.4 Accordingly,
large variety of surgical approaches for this anomaly have
een used, ranging from valve replacement to various types
f valve repair, 1½ ventricle “repair,” univentricular palli-
tion, and transplantation. Initially, after the first report of
rosthetic valve replacement for Ebstein anomaly in 1963,6
alve replacement was the mainstay of surgical therapy for
his condition, but results were not satisfactory.7 In 1964,
ardy and colleagues8 introduced a technique of valve repair
hich, based on the concept of Hunter and Lillehei,9 em-
hasized exclusion of the atrialized portion of the RV by
ransverse plication, transposing the displaced leaflets to the
rue annulus and reducing the size of the dilated annulus. As
he focus of surgery shifted away from valve replacement,
umerous types of repair were devised and refined, and
ndeed excellent outcomes have been reported from various
enters. Danielson and colleagues’10 modification of the Hardy
epair (to which posterior TV annuloplasty and reduction
ight atrioplasty were added) was reproducibly effective
nd became a very popular, “standard” repair technique.
arpentier,5 Chauvaud,11 and their associates introduced a
ifferent repair approach involving temporary detachment
f the anterior TV leaflet to achieve its complete mobiliza-
ion, longitudinal plication of the atrialized RV, clockwise
dvancement of the anterior TV leaflet (which may be
ugmented with pericardium),12 and posterior tricuspid an-
uloplasty (with prosthetic ring placement), resulting in a
onocusp valve. Quaegebeur,13 Chen,14 and their colleagues
lso developed a similar technique, without prosthetic ring
nnuloplasty. Vargas and coworkers15 introduced the con-
ept of “annuloplasty” at the level of the displaced leaflets,
licating the atrialized RV above the level of the recon-
tructed valve. Others (Augustin,16 Schmidt-Habelmann,17
etzer,18 Friesen,19 and their associates) have challenged
he value of plication of the atrialized RV and have simpli-
Abbr eviations and Acronyms
ASD  atrial septal defect
ECHSA European Congenital Heart Surgeons
Association
RV  right ventricle/ventricular
TV  tricuspid valveed the repair by performing only a posterior plication of
ic and Cardiovascular Surgery ● Volume 132, Number 1 51
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Dhe “annulus,” leaving the atrialized chamber untouched
bove the resulting monocusp valve. More recently, new
ariations of repair techniques have been reported. These
nvolve mobilization of all TV leaflets and transposition of
he septal and posterior leaflets to the true annulus, without
lication (the ventricularization method of Ullmann and
olleagues20) or even with longitudinal excision of the atri-
lized ventricle (Wu and Huang21) in an attempt to re-
stablish a trileaflet valve.
Despite excellent results reported, most repair series
ncompass a small number of patients extending over many
ears, usually excluding the most severe cases of type D
isease. In addition, even in the most experienced valve
epair centers, there has been increasing realization that
esults of repair (even for “higher risk” type B and C lesions)
an be improved considerably if the RV is unloaded by a
oncomitant cavopulmonary (Glenn) shunt, that is, by a 1½
entricle repair.11,22,23 Furthermore, in many series there are
cattered references to a few severe cases (type D) that
equired a univentricular approach, in addition to the symp-
omatic neonates who are converted to a univentricular
irculation early in life by a Starnes operation24 and are
herefore subsequently tracked toward Fontan palliation.24-28
inally, valve replacement (without atrialized RV plication)
ontinues to appear in various reports as a good option for
any nonpediatric patients and also seems to be associated
ith good long-term results.29,30
Given the preference, supported by excellent reported
esults, of some well-known centers toward one or another
f the many available types of surgical procedure for Eb-
tein anomaly, and also that most centers’ experience with
his condition is limited to a small number of patients
ccumulated over decades, we sought to analyze the collec-
ive experience of participating institutions of the ECHSA
ith the full spectrum of types and results of surgery for
bstein anomaly in Europe in the current era.
ethods
he records of all 150 patients with the diagnosis of Ebstein
nomaly who underwent surgical therapy in 1 of the 13 partic-
pating ECHSA centers between January 1992 and January
005 were reviewed retrospectively. Patients with congenitally
orrected transposition and “Ebsteinoid” malformation of the
ystemic atrioventricular valve were excluded. Demographic
nd functional parameters were evaluated, including age, gen-
er, weight, functional class, presence and degree of cyanosis,
ardiothoracic ratio, presence of preoperative arrhythmias, prior
perations, echocardiographic and/or angiocardiographic data,
nd associated anomalies. The various types of surgical proce-
ures performed were categorized as valve replacement, valve
epair, 1½ ventricle repair (if valve repair or replacement with
losure of atrial communication was supplemented by a Glenn
hunt), palliative (systemic or cavopulmonary [Glenn] shunt or
ontan operation), or other complex or miscellaneous procedures.
ssociated procedures and operative variables (cardiopulmonary f
2 The Journal of Thoracic and Cardiovascular Surgery ● July 2ypass and aortic crossclamp times) were also noted. Surgical
utcome parameters (including mortality, causes of death, compli-
ations, and functional outcome, when available) were evaluated.
tatistical Analysis
ospital mortality was defined as death during surgery or within
0 days of surgery, according to the definition used in the ECHSA
atabase (now the European Association of Cardiothoracic Sur-
ery database). Ratios are given with 95% confidence limits. A
onparametric test for trend was used to assess the univariate
ssociation between mortality and age and between mortality and
umber of operations, while the association between mortality and
ype of procedure was assessed by a 2 test. Moreover, a nonpara-
etric Mann-Whitney test was used to assess the association
etween age as a continuous variable and mortality, as well as
umber of operations as a continuous variable and mortality. A
nivariate logistic regression model was used to estimate the odds
or death (along with their 95% confidence intervals) by age, type
f operations and number of operations. Multivariable logistic
egression was carried out to assess the independent effect of age,
ype of operation, and number of operations on mortality. This
rocess was repeated for age and number of operations as contin-
ous rather than categorical variables. All statisitcal analyses were
arried out in SPSS version 11.0 (SPSS, Inc, Chicago, Ill).
esults
atient ages ranged from 1 day to 48.3 years (9.5  10.2
ears [mean  standard deviation], median 6 years). Age
istribution is shown in Figure E1. Patient weights ranged
rom 2 to 87 kg (28.4  21.9 kg, median 20 kg). Eighty
atients (53.4%) were female. Participating centers and
orresponding number and age of patients are shown (listed
n random order) in Table E1. Most patients were symp-
omatic, with 3% in New York Heart Association class I,
6% in class II, 52% in class III, and 9% in class IV
reoperatively. Cyanosis was common, with median oxygen
aturation 87% (mean 83.5%  15.8%). Cardiomegaly was
prominent feature, with a median cardiothoracic ratio of
6%. Most patients (80%) were in sinus rhythm (in 52%
ight bundle branch block was noted), 8% had Wolff-
arkinson-White syndrome, 9% had atrioventricular block
8.7% first degree and 0.66% second degree), and 3% had
upraventricular arrhythmias. Prior surgical procedures had
een performed in 24 patients (16%) and included TV
eplacement in 5, repair in 9, 1½ ventricle repair in 1, and
arious palliative operations in 8 patients. In 67% of pa-
ients the diagnosis was established by echocardiography
lone, in 31% by both echocardiography and cardiac cath-
terization study, and in 2% only catheterization had been
erformed. Of the patients who had an explicit severity
rade assigned to them (n  120), 8.3% were considered to
ave type A anatomy, 50% type B, 30.8% type C, and
0.8% type D (Figure E2). TV annular displacement was
evere in 29.8% and moderate in 51.7% of patients. RV
unction was assessed by echocardiography and graded as
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Dormal in 8.8% of patients and mildly impaired in 23%,
hereas 51.3% had moderate and 16.8% severe RV dys-
unction. In 106 cases (70%) the presence of an ASD was
xplicitly recorded. Anatomic and functional features, asso-
iated lesions, and preoperative risk factors are summarized
n Table 1.
The surgical procedures performed (n  179) included
alve replacement (n  60, 33.5%), valve repair (n  49,
7.3%), 1½ ventricle repair (n  46, 26.2%), palliative
hunt (n  13, 6.7%), and other complex or miscellaneous
rocedures (n  11, 8.5%). The distribution of these pro-
edures is depicted in Figure 1, whereas details of these and
ABLE 1. Clinical characteristics, associated lesions and
reoperative risk factors (as percentage of the total num-
er of patients, n  150)
NYHA (%)
Class I 3
Class II 36
Class III 52
Class IV 9
Grade of Ebstein anomaly (%)
Grade A 8.3
Grade B 50
Grade C 30.8
Grade D 10.8
TV annular displacement (%)
Mild 8.7
Moderate 51.7
Severe 34
RV function (%)
Normal 8.8
Mild 26
Moderate 58
Severe 19
ASD (%) 70
VSD (%) 7.33
Pulmonary atresia (%) 6.66
WPW syndrome (%) 8
DiGeorge syndrome (%) 0.66
Guilber syndrome (%) 2
Other chromosomal anomalies (%) 2.66
Acidosis (%) 1.33
Pulmonary hypertension (%) 0.66
Mechanical ventilatory support (%) 4.66
Endocarditis (%) 4
Septicemia (%) 3.33
Neurologic deficits (%) 6.66
Seizures (%) 0.66
Renal anomaly (%) 2
Other (%) 7.33
YHA, New York Heart Association; TV, tricuspid valve; ASD, atrial septal
efect; VSD, ventricular septal defect; WPW, Wolff-Parkinson-White
yndrome.ssociated procedures are summarized in Table E2. t
The Journal of ThoracOf the surgical procedures performed, 150 (83.7%) were
rst-time operations and included (1) TV replacement in 51,
2) repair in 47 (17 Carpentier, 8 Danielson, 1 Vargas, 1
uaegebeur, 2 De Vega, 1 Knott-Craig plasty, and 17 other
ypes of valve repair), (3) 1½ ventricle repair in 36 (16 had
V repair and Glenn shunt, 13 TV replacement and Glenn
hunt with or without concomitant VSD and/or ASD clo-
ure, and 7 had various other procedures), (4) palliative
rocedures (eg, systemic-pulmonary shunt) in 12 cases, and
5) miscellaneous other procedures in 4 patients. In 24
atients, 30 reoperations were performed, including 9 TV
eplacements, 2 TV repairs, 11 1½ ventricle operations (in
0 patients), a palliative procedure (in 1 patient), and 7 other
rocedures (in 4 patients). Median cardiopulmonary bypass
ime was 98 minutes (mean 105  38 minutes), and median
rossclamp time 54 minutes (mean 57  25 minutes).
There were 20 hospital deaths (operative mortality 13.3%,
5% confidence interval 8.3%-19.8%). Causes of death
nclude 12 (60%) cardiac (low cardiac output, cardiac arrest,
ulmonary hypertension, Glenn thrombosis) and 8 (40%)
oncardiac (eg, pneumonia, sepsis, respiratory, renal, or
ultiple organ failure). Differences in operative mortality
etween institutions did not reach statistical significance.
perative mortality according to type of surgical procedure
as 5 of 54 (9.2%) in valve replacement, 3 of 42 (7.1%) in
alve repair, 7 of 42 (16.6%) in 1½ ventricle repair, 3 of 4
75%) in palliative procedures, and 2 of 8 (25%) in miscel-
aneous procedures. This distribution is shown graphically
n Figure 2 and summarized in Table E3, along with results
f univariate analysis of the association of mortality with
ype of procedure. The large and clinically very important
ifferences in mortality among the five types of operative
rocedures are statistically significant overall (P  .01).
he highest mortality was noticed for palliative procedures,
ollowed by other types of procedures, 1½ ventricle repair,
alve replacement, and valve repair. Compared with pallia-
igure 1. Distribution of the various types of surgical procedures
erformed for Ebstein anomaly.ive procedures, the odds for death were significantly lower
ic and Cardiovascular Surgery ● Volume 132, Number 1 53
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Dor 1½ ventricle repair, valve repair, and valve replacement
rocedures. Pairwise comparisons of repair versus replace-
ent (odds ratio 1.32, P  .71), repair versus 1½ ventricle
epair (odds ratio 2.6, P  .17), and replacement versus 1½
entricle repair (odds ratio 1.96, P  .27) showed that the
bserved and potentially clinically important differences did
ot reach statistical significance.
The relationship between age and mortality is shown
raphically in Figure 3 and summarized in Table E3, along
ith results of univariate analysis, which demonstrated that
s age decreases, mortality increases, being significantly
igher in the infant and neonate age groups. This clinically
mportant finding of statistically significant association of
igher mortality with younger age is also confirmed when
ge is treated as a continuous variable (odds ratio 0.67,
onfidence interval 0.54-0.83, P  .001).
Notably, although reoperation(s) were associated with a
rend toward higher mortality, this did not achieve statistical
ignificance (P  .58).
Analysis of the multivariable association between mor-
ality and age, type of operation, and number of opera-
ions, depicted graphically in Figure E3 and summarized in
able E3, showed that only younger age was independently
ssociated with mortality (P  .02).
Important postoperative parameters included mechanical
entilation time (median 1 day), intensive care unit stay (2
ays), and hospital stay (16.5 days). Postoperative compli-
ations occurred in 114 patients (76%), included arrhyth-
ias, delayed sternal closure, and low cardiac output, and
re summarized in Table E4.
iscussion
eflecting the great anatomic heterogeneity of Ebstein anom-
ly, the clinical presentation of patients with this condition
equiring surgical therapy also varies widely, but some
eneralizations can be made from this study. Most patients
igure 2. Distribution of operative mortality according to the type
f surgical procedure.ith Ebstein anomaly coming to surgery in the participating (
4 The Journal of Thoracic and Cardiovascular Surgery ● July 2enters presented in childhood (median age 6 years), were at
east moderately symptomatic (60% New York Heart As-
ociation class II-IV), and had mild-to-moderate cyanosis
median oxygen saturation 87%) and increased cardiotho-
acic ratio (median 66%), whereas a significant percentage
16%) had one or more prior operations. Echocardiography
lone seems to be the most useful diagnostic tool. Although
ost patients were judged to have type B or C disease
uitable for biventricular repair (valve replacement or some
ype of repair), many patients had severe enough disease
hat necessitated either a 1½ ventricle repair (addition of
Glenn shunt) or even various univentricular palliative
perations.
Many centers of excellence focusing on one particular
ype of surgical approach for Ebstein anomaly have reported
utstanding results with their preferred procedure (be it
ome variation of repair or replacement) for most of their
atients (albeit frequently these series do not include pa-
ients at the extremes of age or disease). However, our results
ndicate that, across many European centers, the patient
opulation with Ebstein anomaly is served by a wide variety
f surgical procedures. Almost two thirds of operations (n
09, 61%) were biventricular repairs, that is, valve replace-
ent or repair, with more replacements (33.5%) than repairs
27.5%). It is noteworthy that 25.6% of procedures (n 46)
ere 1½ ventricle repairs, whereas 13.4% (n 24) involved
niventricular palliation or other complex procedures for
evere disease, presumably owing to serious impairment
f RV function. Because of the retrospective and multi-
nstitutional nature of the study, it was not possible to
elineate precise criteria used by participating centers for
hoosing different procedures. However, there was an ob-
ious association of various palliative and complex proce-
ures and very young age and a tendency toward valve
eplacement rather than repair in older children, as well as
oward 1½ ventricle repair in older patients.
Importantly, although operative mortality was not low
Figure 3. Distribution of operative mortality by age group.13.3%), it was associated with palliative surgery and very
006
y
i
c
v
o
a
p
a
o
t
o
m
c
e
a
s
t
a
v
t
r
t
t
a
c
o
r
o
o
b
G
a
p
d
s
p
s
W
E
c
i
i
t
t
a
s
p
o
w
L
T
c
s
n
t
t
m
t
e
s
w
t
a
p
w
I
a
c
(
w
p
i
m
i
s
c
a
c
t
f
H
u
p
a
C
S
Z
G
s
D
t
R
Sarris et al Surgery for Congenital Heart Disease
CH
Doung age. Although only younger age emerged as an
ndependent predictor of death on multivariable analysis,
linically, palliative surgery was clearly associated with
ery young age (especially neonates and infants), whereas
perative mortality was significantly lower in older children
nd zero beyond the first decade of life. Cause of death was
rimarily cardiac failure, while sepsis, respiratory failure,
nd organ failure may have been facilitated by low cardiac
utput in several cases. These findings underscore the fact
hat Ebstein anomaly is a disease not only of the TV but also
f the RV and support the principle of management of this
alformation depending on age at manifestation, clinical
ondition, anatomic severity, and associated malformations,
mploying an eclectic approach rather than attempting to
lways use the same procedure.
It is widely accepted and confirmed by our data that
ymptomatic neonates and infants with Ebstein anomaly
end to have complex anatomy, worse pathophysiology, and
generally unfavorable prognosis. This is the case despite
arious conservative or aggressive approaches, including
emporizing with prostaglandin E1 infusion while awaiting
eduction in pulmonary vascular resistance28 or converting
he heart into single ventricle physiology (Starnes opera-
ion24), although early comprehensive biventricular repair
dvocated by Knott-Craig and associates27 has been asso-
iated with improved outcome in some patients.
The higher observed mortality of 1½ ventricle repair in
ur data (compared with reports in the literature11,22,23) may
eflect more severe underlying disease in this subgroup in
ur series. Conversely, it is possible that some patients in
ur replacement or repair subgroups may have possibly
enefited from the unloading effect of a supplementary
lenn shunt with consequent reduced mortality.
With regard to possible further analysis of outcomes
ccording to specific type of repair and underlying anatomic
arameters, the heterogeneity of types of surgical proce-
ures performed, as detailed in Table E2, and of various
election criteria used in participating institutions did not
ermit any definitive conclusions.
Although 8% of patients had Wolff-Parkinson-White
yndrome, only one surgical ablation procedure (surgery for
PW [n  1]) was reported in our series (listed in Table
2). It is likely that, in many institutions, interventional
atheter techniques may have been used at various time
ntervals either preoperatively or postoperatively, but such
nformation on the cardiologic management of these pa-
ients was not collected in our study.
Our study design and limitations did not permit evalua-
ion of long-term functional outcome in these patients. Such
n analysis is clearly of paramount importance when con-
idering the relative merits of the great variety of surgical
rocedures used but very difficult to achieve given the rarity
The Journal of Thoracf the condition and the length of follow-up necessary,
hich ideally ought to be measured in decades.
imitations
his study is limited by its nature as a retrospective study
arried out in different institutions in 13 different countries
panning a 13-year period. As a consequence, the data are
ot homogeneous, with two thirds being contributed by just
wo centers. Accordingly, the small number of patients
reated at most centers does not permit a meaningful assess-
ent of the effect of center volume on outcome. However,
he data represent the total and unselected surgical experi-
nce of the participating ECHSA institutions during the
tudy period. Furthermore, although all patients who under-
ent surgery for Ebstein anomaly at the participating insti-
utions were recorded in the home surgical databases and
nalyzed, it was not possible to gather information on all
atients with this diagnosis who did not have surgery but
ere being followed up medically during the study period.
t was not possible to collect detailed echocardiographic
nd/or cardiac catheterization information that would permit
lassification of all patients into one of the established
Carpentier scheme) severity grades of the disease. Like-
ise, because of variations in patient populations served by
articipating centers and variability in organization of med-
cal care in different countries, complete follow-up infor-
ation could not be obtained for most patients. Accord-
ngly, it seems desirable to design a long-term prospective
tudy that will ensure the use of uniform criteria to (1)
haracterize the severity of disease and (2) standardize
ssessment of the anatomic, physiologic, and overall clini-
al outcome (including objective assessment of exercise
olerance) of the different types of surgical procedures used
or the management of Ebstein anomaly.
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ted by their participation in discussions of the study design and
reliminary findings during ECHSA scientific sessions. We also
cknowledge participating investigators Dimitrios Bobos, MD,
onstantinos Kontrafouris, MD, Michael Mylonakis, MD, Ioanna
ofianidou, MD, Chryssoula Panayotou, RN, and Prodromos
avaropoulos, CP (Onassis Cardiac Surgery Center, Athens,
reece), who assisted with data collection and/or clinical care of
tudy patients. Special mention must be made of Ms Katerina
imitriou (Navigant Research, Athens, Greece), whose contribu-
ion as our statistical consultant was extremely valuable.
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iscussion
r Gordon K. Danielson (Rochester, Minn). Dr Sarris, I would
ike to congratulate you and the members of the ECHSA for this
arge review from 13 centers over 13 years.
Controversy still exists regarding Ebstein anomaly. Can you
raw conclusions from your review of these medical centers re-
arding 3 questions I’d like to ask?
First, we all agree that a competent TV repair is the ideal.
owever, not all valves can be repaired and it is known that the
V is myopathic and does not tolerate tricuspid regurgitation well.
t is also known that all tricuspid bioprostheses will ultimately
eed to be replaced. Now, the question is this: is it better for the
atient to leave the operating room with a competent TV even
hough it means bioprosthetic valve replacement, or is it acceptable
o reduce the tricuspid regurgitation with a repair by only 1 or 2
chocardiographic grades as some medical centers have sug-
ested?
Dr Sarris. Dr Danielson, first let me thank you for your kind
omments. It is certainly an honor to have our paper discussed by
ne of the world’s authorities on this disease, the Dean of Ebstein
urgery, as Dr Williams mentioned.
Your question is obviously an important one. We cannot truly
nswer it directly based on our data, especially since, as I men-
ioned in the limitations section of this study, there was no uniform
pproach necessarily in all participating centers in how Ebstein
isease is handled. However, the data do suggest that, probably in
ost of the participating centers, there is a preference toward
eaving the operating room with as good a valve as possible, since
ore valve replacements have been performed in this series than
alve repairs. Clearly, this distribution of procedure type is differ-
nt from what some centers have reported, for example, Carpen-
ier’s group, with almost universal application of repair. Thus, I
elieve our data show that the practice in the participating centers
s more along what you are suggesting and what you have
reached.
Dr Danielson. The second question is in regard to the addition
f a bidirectional cavopulmonary shunt at the time of operation.
here are some downsides to that shunt that aren’t usually men-
ioned. These include prolonging the operative time, limiting ac-
ess to the heart for catheter procedures at a later time (such as for
iagnosis and treatment of arrhythmias), and the late systolic
ulsations that develop in the head and neck of some patients.
Can you draw conclusions from this study about what you think
he prevailing criteria are for performing this shunt at the time of
peration? Also, if the decision is made to perform this shunt, is
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Dhat decision made preoperatively, intraoperatively, or at the time
f weaning from cardiopulmonary bypass?
Dr Sarris. Again, our data do not allow us to answer this
uestion precisely because each center has handled patients ac-
ording to its own protocol. This is a retrospective study, the
urgical approach was not uniform across centers, and conse-
uently it is not possible for us to discern whether the decision to
dd a cavopulmonary shunt was made preoperatively or intraop-
ratively.
However, we can answer this question indirectly by noting that
here is a substantial proportion of patients with advanced disease,
s judged by either echocardiography or degree of annular dis-
lacement or by the Carpentier grade, and many of our patients did
eceive supplementary cavopulmonary shunts in conjunction with
ither valve repair or replacement. I can only presume that these
atients were the ones with more severe disease, but it is not
ossible to know whether the decision was made preoperatively or
ostoperatively.
Dr Danielson. The last question relates to atrial arrhythmias. If
here is a history of arrhythmias preoperatively, are they treated
urgically at the time of operation, or are they left to be treated
ater, if possible, by catheterization techniques, as some centers
ecommend?
Dr Sarris. Indeed, our data showed that a significant fraction of
atients had arrhythmias. Preoperatively 8% had Wolff-Parkinson-
hite syndrome. Postoperatively, the most common complication,
s mentioned in the manuscript, was arrhythmias. However, in this
etrospective multi-institutional study, we did not have data re-
arding whether arrhythmias, particularly Wolff-Parkinson-White
yndrome, were treated by catheter-based intervention or intraop-
ratively.
Dr Christian Kreutzer (Buenos Aires, Argentina). I am quite
urprised by the bad results that you show us with a 1½ ventricle
epair. Tchervenkov, 5 years ago, presented at the meeting of this
ssociation a wonderful series of valvuloplasties in which the
idirectional Glenn shunt was a protective factor for early survival
unpublished data; 2000).
I wonder if the reason for the low results is the association of
bidirectional Glenn with a valve replacement. I think when you
o a bidirectional Glenn, you unload the right ventricle, and the
ow that you have going through the prosthetic valve is so low that
he valve gets clotted or invaded with pannus.
We have done that in Argentina a few times, and we have
bandoned that idea because the function of the valve gets disas-
rous in a few months. I think it is a real contraindication to do the
idirectional Glenn with a valve replacement.
Do you notice any difference in between mortality in 1½
entricle repairs between valve replacements and valve plasties?
Dr Sarris. There was no difference in mortality between these
wo subgroups. Approximately half of the 1½ ventricle repair
atients in our study had valve repairs and the other half had valve
eplacement, both supplemented with bidirectional cavopulmonary
hunts. d
The Journal of ThoracWe are aware of the reports in the literature of much lower
ortality in 1½ ventricle repairs, but we believe that the difference
etween those reports and our findings must pertain to the patient
opulation that was subjected to this operation. Clearly, if the
riteria for using 1½ ventricle repair are relaxed, then the overall
esults of this approach will be better. It is possible that if more 1½
entricle repairs were performed in this particular cohort of pa-
ients, that is, with more liberal criteria, then this particular sub-
roup would have lower mortality.
Dr Carlo F. Marcelletti (Palermo, Italy). I believe this group
f patients that you have reported is quite inhomogeneous. They
ave only the name of the basic disease in common. However, if
ou try to look at different groups by age, you find that the
eonatal age is the age when the Ebstein anomaly is basically not
reatable, because the disease not only involves the heart but
ostly involves the lungs. Severe Ebstein anomaly at that age
nvolves undeveloped lungs. I think most of us who have tried to
o any type of palliation between 0 and 30 days of age have always
ailed.
In our center, we like to consider neonates with Ebstein anom-
ly to be medical patients. The administration of prostaglandin and
itrous oxide is probably the best palliation that we can use.
Dr Sarris. Your question?
Dr Marcelletti. Why did you put the neonates in this group of
atients? They are absolutely a different subset of patients. I think
hey have nothing to do with patients who undergo valve replace-
ent, 1½ ventricle repair, because they are not treatable.
Dr Sarris. We are well aware that the neonates and infants are
special subgroup with much more severe presentation and higher
ortality no matter what you do, whether you apply a more
onservative approach of watching and using prostaglandin, or a
ore radical approach such as conversion to a single ventricle
hysiology, the Vaughn Starnes approach, or using what may be
erhaps an even more aggressive approach, the Knott-Craig type
f repair. There are reports in the literature of reasonable results
ith all of these approaches.
Once again, this is a retrospective study documenting the
ractice of Ebstein surgery in 13 participating ECHSA centers, and
here is no uniform approach across these centers. The results do
onfirm what you have just said, that surgical mortality is much
igher in the neonates and infants. It is 50%, but there are survi-
ors. Our study documents the practice of Ebstein surgery for all
ge groups in the participating institutions.
Dr Hillel Laks (Los Angeles, Calif). In older children, meaning
ot neonates or infants, we have found that there is a higher risk
nd more difficulty postoperatively in those who have ASDs with
ight-to-left shunts. In that group, rather than using a bidirectional
lenn, we use an adjustable ASD, which can then subsequently be
losed as the RV recovers. We found this extremely useful in
educing the postoperative difficulty. Was this used in any of these
atients as opposed to the bidirectional Glenn?
Dr Sarris. I don’t believe so, although this is an approach that
ou have introduced and popularized for a number of reasons. I
on’t believe that this was used in any of these patients.
ic and Cardiovascular Surgery ● Volume 132, Number 1 57
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DFigure E1. Age distribution as percentage of total number of patients (n  150) by age subgroup.
ABLE E1. Participating centers with corresponding number and ages of patients*
enter No. of patients
Age
(median, y) Age range
1 21 3.5 4 d-44.8 y
2 4 13.4 8.5-35.4 y
3 3 11.8 1 d-15.9 y
4 3 47.4 46.6-48.3 y
5 6 1.6 3 d-21.6 y
6 6 2.8 3 d-31.8 y
7 3 31 3-33 y
8 78 6.8 25 d-47.4 y
9 10 7.2 1 d-21 y
10 5 18.4 6.2-45.2 y
11 8 5.6 1.1-11.1 y
12 1 15.9 15.9 y
13 2 8.9 5.5-12.4 y
otal 150 6.4 1 d-48.3 yIn random order.
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Digure E2. Patient distribution into the types of Ebstein anomaly
ccording to Carpentier’s classification.CHABLE E2. Types of procedures performed (n  179)
eplacement
(n  60)
Replacement
TV ( ASD
repair)
(n  58)
Replacement TV
 ASD  VSD
repair (n  2)
epair (n  49) Carpentier
(n  17)
Danielson (n  8) Other valve repair
(n  20)
Vargas (n  1) DeVega (n  2) Knott-Craig
(n  1)
½ ventricle
repair
(n  46)
Valve repair 
Glenn
(n  16)
Hemi-Fontan
(n  2)
Valve replacement
 Glenn
(n  13)
Glenn  ASD
closure (n  10)
TV replacement
 Glenn 
VSD (n  2)
Glenn  RVOT
resection
(n  1)
Glenn  PV
replacement
(n  2)
alliation
(n  13)
mBT shunt 
PDA closure
(n  5)
Central shunt
(n  2)
Fontan (n  1)
Central shunt  ASD
enlargement  TV
closure (n  1)
mBT shunt 
TV closure
(n  1)
mBT Shunt 
PVotomy
(n  2)
mBT shunt  TV
closure 
atrial septation
(n  1)
ther (n  11) Pacemaker
(n  2)
PDA closure
(n  2)
Ablation (n  1) Other (n  6)
V, Tricuspid valve; ASD, atrial septal defect; VSD, ventricular septal defect; RVOT, right ventricular outflow tract; PV, pulmonary valve; mBT shunt, modified
lalock-Taussig shunt; PDA, patent ductus arteriosus.
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DABLE E3. Analysis of operative mortality
ortality by type of procedure Total Dead Mortality (%) (95% CI)
Univariate OR for
death (95% CI) P value
ype of operation
Palliative 4 3 75 (19.4-99.4) 1.0
1½ 42 7 16.6 (6.9-31.3) 0.06 (0.006-0.74) .03
Repair (TV plasty) 42 3 7.1 (1.5-19.5) 0.025 (0.002-0.33) .005
Replacement 54 5 9.2 (3.0-20.3) 0.034 (0.003-0.39) .007
Other 8 2 25.0 (3.2-65.1) 0.11 (0.007-1.77) .12
verall 150 20 13.3 (8.3-19.8) .01
ortality by age group Total Dead Mortality (%) (95% CI)
Univariate OR for
death (95% CI) P value
ge
0-30 d 13 7 53.8 (25.1-80.7) 1.0
1 mo-1 y 6 3 50 (11.8-88.2) 0.86 (0.12-5.94) .87
1-2 y 10 3 30 (6.7-65.2) 0.37 (0.06-2.08) .26
2-5 y 28 4 14.3 (4-32.6) 0.14 (0.03-0.65) .012
5-10 y 31 3 9.7 (2-25.7) 0.09 (0.02-0.46) .004
10-20 y 39 0 0 — —
20-40 y 11 0 0 — —
40 y 5 0 0 — —
verall* 123 20 13.98 (8.7-20.7) .001
ultivariable association between age, type of procedure, number of operations, and mortality
isk factors Multivariate odds for dying (95% CI) P value
ge 0.69 (0.55-0.87) .02
ype of procedure
Palliative 1.0 .62
1½ 0.30 (0.02-3.85) .36
Repair (TV plasty) 0.15 (0.01-2.13) .16
Replacement 0.35 (0.02-5.0) .44
Other 0.54 (0.02-13.5) .71
o. of operations 0.87 (0.26-2.84) .82I, Confidence interval; OR, odds ratio; TV, tricuspid valve. *Information is missing for the ages of 7 surviving patients.
F
t
7.e3 The Journal of Thoracic and Cardiovascular Surgery ● Juligure E3. Graphic depiction of the relationship of age group,
ype of procedure, and mortality.
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DABLE E4. Postoperative complications noted in 114 patients
omplications No. of patients %
rrhythmia 39 34.3
ternum left opened 18 15.8
emporary complete AV block requiring pacemaker 17 14.9
ow cardiac output 12 10.5
neumonia 8 7
ericardial effusion requiring drainage 7 6.1
leural effusion requiring drainage 7 6.1
ardiac arrest 7 6.1
ystemic vein obstruction 6 5.3
cute renal failure requiring temporary dialysis 4 3.5
espiratory insufficiency requiring mechanical ventilatory support  7 d 4 3.5
ulmonary hypertension crises (PA pressure  systemic pressure) 4 3.5
ermanent complete AV block requiring pacemaker 4 3.5
ound infection 4 3.5
epticemia 4 3.5
eurologic deficit persisting at discharge 4 3.5
racheostomy 2 1.8
leeding requiring reoperation 2 1.8
ediastinitis 1 0.9
hylothorax 1 0.9
ound dehiscence 1 0.9
ther 1 0.9V, Atrioventricular; PA, pulmonary artery.
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